يعرض 1 - 20 نتائج من 20 نتيجة بحث عن '"adverse effects [Antineoplastic Combined Chemotherapy Protocols]"', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2

    المصدر: Contemporary clinical trials 49, 1-5 (2016). doi:10.1016/j.cct.2016.05.007

  3. 3

    المساهمون: von Minckwitz, Gunter, Puglisi, Fabio, Cortes, Javier, Vrdoljak, Eduard, Marschner, Norbert, Zielinski, Christoph, Villanueva, Cristian, Romieu, Gille, Lang, István, Ciruelos, Eva, DE LAURENTIIS, Michelino, Veyret, Corinne, de Ducla, Sabine, Freudensprung, Ulrich, Srock, Stefanie, Gligorov, Joseph

    المصدر: The Lancet Oncology. 15:1269-1278

    مصطلحات موضوعية: Oncology, Time Factors, genetic structures, medicine.medical_treatment, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, genetics, skin and connective tissue diseases, Humanized, education.field_of_study, Medicine (all), drug therapy/genetics/mortality/pathology, Remission Induction, Middle Aged, Metastatic breast cancer, Bevacizumab, Treatment Outcome, Local, Retreatment, metastatic breast cancer, Drug, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Combination therapy, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, administration /&/ dosage/adverse effects, Antibodies, Disease-Free Survival, Drug Administration Schedule, methods, Dose-Response Relationship, Breast cancer, Internal medicine, medicine, Humans, Neoplasm Invasiveness, education, Survival analysis, Aged, erbB-2, drug therapy/mortality/pathology, Neoplasm Staging, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Patient Selection, Genes, erbB-2, medicine.disease, Survival Analysis, eye diseases, Neoplasm Recurrence, Genes, pathology, sense organs, Neoplasm Recurrence, Local, business, Adult, Aged, Antibodies, administration /&/ dosage/adverse effects, Antineoplastic Combined Chemotherapy Protocols, administration /&/ dosage/adverse effects, Breast Neoplasms, drug therapy/genetics/mortality/pathology, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Follow-Up Studies, Genes, genetics, Humans, Maximum Tolerated Dose, Middle Aged, Neoplasm Invasiveness, pathology, Neoplasm Recurrence, drug therapy/mortality/pathology, Neoplasm Staging, Patient Selection, Remission Induction, methods, Retreatment, Survival Analysis, Time Factors, Treatment Outcome, Follow-Up Studies

  4. 4
  5. 5
  6. 6

    المساهمون: Radiology and Nuclear Medicine, Epidemiology, Radiology & Nuclear Medicine, Medical Informatics, Medical Oncology

    المصدر: Human brain mapping, 35(3), 889-899. Wiley-Liss Inc.
    Hum Brain Mapp
    Human brain mapping 35(3), 889-899 (2012). doi:10.1002/hbm.22221
    Human Brain Mapping, 35(3), 889-899. Wiley-Liss Inc.

  7. 7

    المساهمون: Epidemiology, Medical Oncology

    المصدر: Critical Reviews in Oncology/Hematology, 88(1), 87-101. Elsevier Ireland Ltd
    Critical reviews in oncology, hematology 88(1), 87-101 (2013). doi:10.1016/j.critrevonc.2013.04.002

  8. 8

    المساهمون: Epidemiology, Medical Oncology

    المصدر: Journal of Clinical Oncology, 30(10), 1080-1086. American Society of Clinical Oncology
    Journal of clinical oncology 30(10), 1080-1086 (2012). doi:10.1200/JCO.2011.37.0189

    وصف الملف: application/pdf

  9. 9
    Academic Journal

    المصدر: Thatcher , N , Qian , W , Clark , P I , Hopwood , P , Sambrook , R J , Owens , R , Stephens , R J & Girling , D J 2005 , ' Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: Clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial ' , Journal of Clinical Oncology , vol. 23 , no. 33 , pp. 8371-8379 . https://doi.org/10.1200/JCO.2004.00.9969

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14

    المصدر: Scopus-Elsevier

  15. 15
  16. 16

    المصدر: Scopus-Elsevier

    مصطلحات موضوعية: Adult, Infusions, Neutropenia, Fever, Filgrastim, Paclitaxel, Left, Antineoplastic Agents, chemically induced/drug therapy, Breast Neoplasms, administration /&/ dosage/adverse effects, Ventricular Function, Left, Injections, administration /&/ dosage/therapeutic use, Cohort Studies, Antibiotics, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Adult, Aged, Antibiotics, Antineoplastic, administration /&/ dosage/adverse effects, Antineoplastic Agents, administration /&/ dosage/adverse effects, Antineoplastic Combined Chemotherapy Protocols, administration /&/ dosage/adverse effects/therapeutic use, Breast Neoplasms, drug therapy, Chemotherapy, Adjuvant, Cohort Studies, Drug Tolerance, Epirubicin, administration /&/ dosage/adverse effects, Feasibility Studies, Female, Fever, chemically induced, Granulocyte Colony-Stimulating Factor, administration /&/ dosage/therapeutic use, Heart Failure, chemically induced, Heart, drug effects, Humans, Infusions, Intravenous, Injections, Intravenous, Middle Aged, Neutropenia, chemically induced/drug therapy, Paclitaxel, administration /&/ dosage/adverse effects, Peripheral Nervous System Diseases, chemically induced, Recombinant Proteins, Remission Induction, Stroke Volume, drug effects, Ventricular Function, drug effects, Chemotherapy, Ventricular Function, Humans, Infusions, Intravenous, Adjuvant, Aged, Epirubicin, Heart Failure, administration /&/ dosage/adverse effects/therapeutic use, Antibiotics, Antineoplastic, Remission Induction, Peripheral Nervous System Diseases, Heart, Stroke Volume, Drug Tolerance, Middle Aged, Antineoplastic Agents, Phytogenic, Recombinant Proteins, drug therapy, Chemotherapy, Adjuvant, Injections, Intravenous, chemically induced, Feasibility Studies, Female, Intravenous

  17. 17
  18. 18

    المصدر: Scopus-Elsevier

  19. 19
  20. 20

    المصدر: Scopus-Elsevier